Browse > Article
http://dx.doi.org/10.15204/jkobgy.2019.32.1.037

Analysis of the Characteristics and Treatment of Polycystic Ovary Syndrome Patients in a Korean Medicine Hospital  

Park, Seung-Hyeok (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
Lee, Jin-Moo (Dept. of Korean Medicine Gynecology, College of Korean Medicine, Kyung Hee University)
Lee, Chang-Hoon (Dept. of Korean Medicine Gynecology, College of Korean Medicine, Kyung Hee University)
Jang, Jun-Bock (Dept. of Korean Medicine Gynecology, College of Korean Medicine, Kyung Hee University)
Hwang, Deok-Sang (Dept. of Korean Medicine Gynecology, College of Korean Medicine, Kyung Hee University)
Publication Information
The Journal of Korean Obstetrics and Gynecology / v.32, no.1, 2019 , pp. 37-47 More about this Journal
Abstract
Objectives: The purpose of this study was to analyze the current characteristics and prescriptions of outpatients with Polycystic Ovary Syndrome (PCOS). Methods: We searched medical records from January 1, 2017 to December 31, 2017 and found out 31 patients who first visited with PCOS. Results: The average age of PCOS patients was $26.48{\pm}5.15years$ old, average height was $162.16{\pm}5.56cm$, average weight was $55.27{\pm}9.34kg$, and average BMI was $21.01{\pm}3.48kg/m^2$ A total of 24 patients who had received western treatment for PCOS in the past, 13 people received oral contraceptions, 4 hormones, 2 metformin, one hormone and metformin, also 4 people were treated for assisted reproductive technologies due to infertility. There were only two patients who combined Korean and Western treatments. The most common menstrual-related symptoms of PCOS patients were oligomenorrhea (48.4%) and dysmenorrhea (22.6%). Other symptoms were the highest in the cold symptoms (54.8%), followed by infertility (9.7%). The average number of patients visiting the hospital was $6.26{\pm}7.2$, with 22 (71.0%) coming from 1 to 5. The average treatment period for patients was $10.1{\pm}10.8weeks$, with 41.9% the largest for 1 to 4 weeks. Acupuncture (93.5%), moxibustion (96.8%) herbmed (96.8%) was treated to most PCOS patients. The most commonly used herbal medicines were Ongyeong-tang (35.5%), Ijin-tang-gami (19.4%), Dodam-tang-gami (12.9%), and Jogyeongjongok-tang-gami (12.9%). Conclusions: These results could be helpful to treat PCOS patients in Korean gynecologic clinical fields.
Keywords
Polycystic Ovary Syndrome; PCOS; Characteristics; Treatment;
Citations & Related Records
Times Cited By KSCI : 11  (Citation Analysis)
연도 인용수 순위
1 Korean Society of Obstetrics and Gynecology. Gynecology. 4th edition. Seoul:Korea Medical Book Publishing Co. 2007:362-71.
2 Boomsma CM, et al. A Meta-analysis of Pregnancy Outcomes in Women with Polycystic Ovary Syndrome. Hum Prod Update. 2006;12(6):673-83.   DOI
3 Kim SH, et al. Recent Acupuncture Therapy for Polycystic Ovary Syndromes : Systematic Review. J Korean Obstet Gynecol. 2014;27(2):71-82.   DOI
4 Kim DI, et al. A Bibliographical Study on Polycystic Ovarian Syndrome. J Korean Obstet Gynecol. 1997;10(1): 73-91.
5 Kwon JM, Park YS, Kim DC. A review of Outpatients in Oriental Obstetric & Gynecology Clinic of the Oriental Hospital for 3 Years. J Korean Obstet Gynecol. 2011;24(4):163-73.   DOI
6 Woo HL, et al. Analysis on Chief Complaints of Outpatients Visiting Korean Gynecology Clinic of Traditional Korean Medicine Hospital in Gangdong-gu, Seoul. J Korean Obstet Gynecol. 2017; 30(1):29-41.   DOI
7 Choi JY, et al. Clinical Data Analysis of 106 Breast Cancer Patients Who Received Oriental Medical Treatment. J Korean Obstet Gynecol. 2008;21(4) :228-36.
8 Jang HJ, et al. Study on Status Changes in Female Infertility who Admitted to Oriental Hospital. J Korean Obstet Gynecol. 2010;23(3):184-91.   DOI
9 Kim NH, et al. Study on Status Survey in Female Infertility Patients Admitted to Korean Medicine Hospital. J Korean Obstet Gynecol. 2013;26(2):120-37.   DOI
10 Kwon JM, Park YS, Kim DC. A review of Outpatients in Oriental Obstetric & Gynecology Clinic of the Oriental Hospital for 3 Years. J Korean Obstet Gynecol. 2011;24(4):163-73.   DOI
11 Jang SR, Park YS, Kim DC. The Clinical Analysis of 104 Sanhupung Patients that visited at an Oriental Medicine Hospital. J Korean Obstet Gynecol. 2010;23(3):192-204.   DOI
12 Hwang YS, et al. Analysis on Outpatients with Postpartum Disease at the Korean Gynecology Clinic of Traditional Korean Medicine Hospital. J Korean Obstet Gynecol. 2018;31(3):61-78.   DOI
13 Bae JE, Park KD, Yoon YJ. The Effect of Integrated Medicine for Polycystic Ovary Syndrome Subfertility Patients; A Systematic Review and Meta-Analysis. J Korean Obstet Gynecol. 2017;30(4):59-76.   DOI
14 Yun SY, Kang MJ. Clinical Study of Oriental Medicine Treatment for Polycystic Ovarian Disease. J Korean Obstet Gynecol. 2000;13(2):437-51.
15 The Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 Consensus on Diagnostic Criteria and Long-term Health Risks Related to Polycystic Ovary Syndrome. Fertil Steril. 2004;81(1):19-25.   DOI
16 Korean Traditional Knowledge Portal. Korean Medicine Term Dictionary[Cited 2019 Jan 8]. Available from:URL: http://www.koreantk.com/ktkp2014/ dictionary/dictionary-view.page.
17 Stein IF, Leventhal ML. Amenorrhea Associated with Bilateral Polycystic Ovaries. Am J Obstet Gynecol. 1935; 29(2):181-91.   DOI
18 Zawadski JK, Dunaif A. Diagnostic Criteria for Polycystic Ovary Syndrome: Towards a Rational Approach. In Polycystic Ovary Syndrome. Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. 1st ed. Boston:Blackwell Scientific. 1992:377-84.
19 Azziz R, et al. The Androgen Excess and PCOS Society Criteria for the Polycystic Ovary Syndrome: The Complete Task Force Report. Fertil Steril. 2009;91(2):456-88.   DOI
20 Huang Z, Yong EL. Ethnic Differences: Is There an Asian Phenotype for Polycystic Ovarian Syndrome? Best Practice & Research Clinical Obstetrics & Gynaecology. 2016;37:46-55.   DOI
21 Korean Acupuncture & Moxibustion Medicine Society. The Acupuncture and Moxibustion II. Gyeonggido:Jipmoondang. 2008:67-71.
22 Kwon SR, et al. Effects of Electro -acupuncture on Sameumgyo(SP-6). Chagung(CA-111) on Polycystic Ovary in Rats. J Korean Obstet Gynecol. 2003;16(2):76-86.
23 Heo J. Donguibogam. Gyeongam: Donguibogamchulpansa. 2010:300-1, 310-1, 1750-1.
24 Kim CW. Study on Onkyung-tang Being Applied by the Gynecology. J Korean Obstet Gynecol. 1998;11(1) :251-65.
25 Yun MH, et al. Effects of Gaeullijin -tang on the Progression of the Estradiol Valerate-induced Polycystic Ovaries in Rats. J Korean Obstet Gynecol. 2010;23(2):1-19.   DOI
26 Yang SJ, et al. Effects of Changbudodam -tang on the Polycystic Ovaries Induced by Estradiol Valerate in Rats. J Korean Obstet Gynecol. 2002;15(2):1-11.
27 Gu HJ, Cho SH. Effects of Gleditsiae Spina on the Polycystic Ovary Induced by Estradiol Valerate in Rats. J Korean Obstet Gynecol. 2010;23(2) :71-84.   DOI
28 Yang JM, et al. Effects of Jokyeongjongok -tang on the Maturation of Follicles and NGF Expression in Rats with Estradiol Valerate-induced Polycystic Ovaries. J Korean Obstet Gynecol. 2011;24(2):52-67.   DOI
29 Ryu KJ, Cho SH. Effects of Angelicae Gigantis Radix on Gene Expression of Ovarian Tissue in Polycystic Ovary Syndrome Rats. J Korean Obstet Gynecol. 2011;24(3):28-47.   DOI
30 Yeo EJ, et al. Effects of Pinelliae Rhizoma on Ovarian Tissue in Polycystic Ovary Syndrome Rats. J Korean Obstet Gynecol. 2012;25(2) :66-77.   DOI
31 Park CI, Park KM. Effects of Cyperi Rhizoma on Relevant Conditions of Metabolic Syndrome in Rats with Polycystic Ovary Syndrome. J Korean Obstet Gynecol. 2011;24(4):20-30.   DOI
32 Lee YK, et al. Effects of Gwibi-tang on the Estradiol Valerate-induced Polycystic Ovaries in Rats. J Korean Obstet Gynecol. 2008;21(3):60-74.
33 Kim JD, et al. Effects of Ojeok-san on the Maturation of Follicles and NGF Expression in Rats with Estradiol Valerate-induced Polycystic Ovaries. J Korean Obstet Gynecol. 2011;24(1) :27-41.   DOI
34 Choi JE, et al. The Effects of Yijin-tang on Body Weight and Ovarian Reaction in Obesity Mice. J Korean Obstet Gynecol. 2003;16(2):68-75.
35 Lee JH, Jung SY, et al. Case Report of 20 Amenorrhea or Oligomenorrhea Patients due to Polycystic Ovarian Syndrome. J Korean Obstet Gynecol. 2016;29(3):47-56.   DOI
36 Lee IJ, et al. Effects of Yongdamsagan -tang on the Progression of the Estradiol Valerate-induced Polycystic Ovaries and on the Conception in Rats. J Korean Obstet Gynecol. 2011;24(3) :48-72.   DOI
37 Nam EJ, et al. Effects of Jeongkyeong-tang on the Estradiol Valerate-induced Polycystic Ovary in Rats. J Korean Obstet Gynecol. 2007;20(1):99-113.
38 Kim HJ, et al. Effects of Changbuyeukgun -tang on the Estradiol Valerateinduced Polycystic Ovaries in Rats. J Korean Obstet Gynecol. 2008;21(2):1-16.
39 Yoo YK, et al. Effects of Shingihwanhapchangbudodam-tang on the Estradiol Valerate-induced Polycystic Ovary in Rats. J Korean Obstet Gynecol. 2007;20(1):84-98.
40 Kim JY, Jung SY. Clinical Study for the One Case that Diagnosed Polycystic Ovarian Disease. J Korean Obstet Gynecol. 2014;27(3):151-7.   DOI